Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 243 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Desc)]
Φίλτρα: Συντάκτης is Kountouras, Jannis  [Clear All Filters]
2019
Katsinelos, T., Doulberis M., Polyzos S. A., Papaefthymiou A., Katsinelos P., & Kountouras J. (2019).  Molecular links between Alzheimer's disease and Gastrointestinal microbiota with its-related metabolic syndrome: emphasis on Helicobacter pylori infection involvement.. Curr Mol Med.
Perakakis, N., Polyzos S. A., Yazdani A., Sala-Vila A., Kountouras J., Anastasilakis A. D., et al. (2019).  Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: a proof of concept study.. Metabolism. 154005.
Polyzos, S. A., Slavakis A., Koumerkeridis G., Katsinelos P., & Kountouras J. (2019).  Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort.. Horm Metab Res. 51(2), 134-140.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2019).  Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.. Metabolism. 92, 82-97.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Vardaka E., Tzivras D., et al. (2019).  A perspective on risk factors for esophageal adenocarcinoma: emphasis on Helicobacter pylori infection.. Ann N Y Acad Sci. 1452(1), 12-17.
Kountouras, J., Doulberis M., Papaefthymiou A., Polyzos S. A., Touloumtzi M., Vardaka E., et al. (2019).  The relationship between -related microbiota dysbiosis and gastrointestinal tract pathologies.. Scand J Gastroenterol. 1-2.
Katsinelos, P., Lazaraki G., Chatzimavroudis G., Anastasiadis S., Georgakis N., Xanthis A., et al. (2019).  A retrospective comparative study of argon plasma versus polypectome snare tip coagulation: effect on recurrence rate after resection of large laterally spreading type lesions.. Ann Gastroenterol. 32(2), 178-184.
Polyzos, S. A., Kountouras J., Mavrouli M., Katsinelos P., Doulberis M., Gavana E., et al. (2019).  Selenoprotein P in Patients with Nonalcoholic Fatty Liver Disease.. Exp Clin Endocrinol Diabetes.
Polyzos, S. A., Perakakis N., Boutari C., Kountouras J., Ghaly W., Anastasilakis A. D., et al. (2019).  Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD.. J Clin Endocrinol Metab.
Doulberis, M., Papaefthymiou A., Kountouras J., Polyzos S. A., Srivastava S., Klokowska-Röetzler J., et al. (2019).  Vitamin D Deficiency and Unclear Abdominal Pain in Patients from Low- and Middle-Income Countries.. Int J Environ Res Public Health. 16(23), 
2020
Doulberis, M., Srivastava S., Polyzos S. A., Kountouras J., Papaefthymiou A., Klukowska-Rötzler J., et al. (2020).  Active Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients.. J Clin Med. 9(4), 
Doulberis, M., Kotronis G., Gialamprinou D., Polyzos S. A., Papaefthymiou A., Katsinelos P., et al. (2020).  Alzheimer's disease and gastrointestinal microbiota; impact of infection involvement.. Int J Neurosci. 1-13.
Doulberis, M., Papaefthymiou A., Polyzos S. A., Bargiotas P., Liatsos C., Srivastava D. Shiva, et al. (2020).  Association between Active Infection and Glaucoma: A Systematic Review and Meta-Analysis.. Microorganisms. 8(6), 
Polyzos, S. A., Kountouras J., Goulas A., Papakonstantinou E., & Papaioannidou P. (2020).  Dissociating nonalcoholic steatohepatitis from hepatocellular carcinoma in obesity.. Hepatobiliary Surg Nutr. 9(1), 73-76.
Polyzos, S. A., & Kountouras J. (2020).  Enriched MACK-3 following CHAI and MACK-3 for the noninvasive diagnosis of nonalcoholic steatohepatitis.. Ann Hepatol. 19(5), 579-580.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Zavos C., & Doulberis M. (2020).  Erratum to: Letter to the editor re: Li et al. (2020), 'The potential role of bacteria in pancreatic cancer: A systematic review'.. Carcinogenesis.
Kountouras, J., Papaefthymiou A., Gavalas E., Polyzos S. A., Boziki M., Kyriakou P., et al. (2020).  Helicobacter pylori infection as a potential risk factor for multiple sclerosis.. Med Hypotheses. 143, 110135.
Doulberis, M., Papaefthymiou A., Polyzos S. A., Kotronis G., Gialamprinou D., Tzitiridou-Chatzopoulou M., et al. (2020).  Helicobacter pylori, Sleeve Gastrectomy, and Gastroesophageal Reflux Disease: Is There a Relation?. Obes Surg.
Polyzos, S. A., Papaefthymiou A., Doulberis M., Katsinelos P., & Kountouras J. (2020).  Homocysteine in nonalcoholic steatohepatitis: seemingly a paradox revisited.. J Gastrointestin Liver Dis. 29(2), 270-271.
Kountouras, J., Doulberis M., Papaefthymiou A., & Polyzos S. A. (2020).  Impact of Helicobacter pylori-linked metabolic syndrome on non-alcoholic fatty liver disease and its connected atrial fibrillation risk.. Liver Int.
Papaefthymiou, A., Doulberis M., Polyzos S. A., Katsinelos P., Liatsos C., Koffas A., et al. (2020).  Letter: Helicobacter pylori in proton pump inhibitor-associated biliary disease.. Aliment Pharmacol Ther. 51(2), 313-314.
Papaefthymiou, A., Doulberis M., Polyzos S. A., Katsinelos P., & Kountouras J. (2020).  Letter: Helicobacter pylori infection and its role in oesophageal adenocarcinoma.. Aliment Pharmacol Ther. 51(11), 1215-1216.
Papaefthymiou, A., Doulberis M., Polyzos S. A., & Kountouras J. (2020).  National consensus on infection: the next-day challenge.. Ann Gastroenterol. 33(3), 324-325.
Polyzos, S. A., Kountouras J., & Mantzoros C. S. (2020).  Obeticholic acid for the treatment of nonalcoholic steatohepatitis: Expectations and concerns.. Metabolism. 104, 154144.
Kountouras, J., Papaefthymiou A., Polyzos S. A., Liatsos C., Zavos C., Vagdatli E., et al. (2020).  Potential Impact of Helicobacter pylori Infection on Reflux Disease Sequence: Illuminating the Gap.. J Clin Gastroenterol. 54(2), 200-201.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.